教育背景
2006—2010: Sichuan University, West China School of Pharmacy, Bachelor of Science
2010—2013: Sichuan University, West China School of Pharmacy, Master of Pharmaceutics
2013—2017: University of Queensland, School of Chemistry and Molecular Biosciences anࣺᯬ
工作经历
项目课题经历
论文、成果、著作等
(1) Yu Wan, Wei Dai, Istvan Toth*, Peter M. Moyle*, Multifunctional peptide-lipid nanocomplexes for efficient targeted delivery of DNA and siRNA into breast cancer cells, Acta Biomaterialia, 2017, 59: 257-268.
(2) Yu Wan, Peter M. Moyle*, Pei Zhi Gn, Istvan Toth*, Design and evaluation of a stearylated multicomponent peptide-siRNA nanocomplexes for efficient cellular delivery, Nanomedicine-UK, 2017, 12(4): 281-293.
(3) Yu Wan#, Peter M. Moyle*#, Michelle P Christie, Istvan Toth*, Nanosized, peptide-based multicomponent DNA delivery systems: optimization of endosome escape activity, Nanomedicine-UK, 2016, 11(8): 907-919.
(4) Yu Wan, Peter M. Moyle*, Istvan Toth*, Endosome Escape Strategies for Improving the Efficacy of Oligonucleotide Delivery Systems, Curr Med Chem, 2015, 22(29): 3326-3346.
(5) Jie Zheng#, Yu Wan#, Abdelbary Elhissi, Zhirong Zhang, Xun Sun*, Targeted Paclitaxel Delivery to Tumors Using Cleavable PEG-Conjugated Solid Lipid Nanoparticles, Pharm Res, 2014, 31(8): 2220-2233.
(6) Yu Wan, Jianfeng Han, Gerui Fan, Zhirong Zhang, Tao Gong, Xun Sun*, Enzyme-responsive liposomes modified adenoviral vectors for enhanced tumor cell transduction and reduced immunogenicity, Biomaterials, 2013, 34(12): 3020-3030.
专利、著作版权等
声明:本站专家信息来源于各高校官网。